Literature DB >> 12226040

Medical literature and vena cava filters: so far so weak.

Philippe Girard1, Jean-Baptiste Stern, Florence Parent.   

Abstract

STUDY
OBJECTIVE: With the development of percutaneous inferior vena cava (IVC) filters, IVC interruption has become a widely used procedure in patients with or at risk for venous thromboembolism. In an attempt at clarifying the indications for filter placement, a systematic literature review was undertaken.
DESIGN: Bibliographic search and analysis. MEASUREMENTS AND
RESULTS: A systematic MEDLINE search about vena cava filters produced a total of 568 references with abstracts between 1975 and 2000 inclusively. Each reference was analyzed according to predetermined criteria. Nearly two thirds (65.0%) of these publications were retrospective studies or case reports (33.3 and 31.7%, respectively), 12.9% were animal or in vitro studies, 7.4% were prospective studies, 6.7% were reviews, and 8.1% reported on miscellaneous related topics. Among the prospective studies, only 16 studies included > or = 100 patients, only 1 study was a randomized controlled trial (0.02% of 568 references), and heterogeneity among series precluded any relevant comparison. In a similar search about heparin and venous thromboembolism, 47.4% of 531 references were randomized controlled trials.
CONCLUSIONS: Until more relevant data become available, literature reviews about vena cava filters will remain narrative, and many if not most indications for filter placement will remain a matter of opinion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226040     DOI: 10.1378/chest.122.3.963

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Metastatic involvement of a retrieved inferior vena cava filter.

Authors:  Ziv Neeman; Aaron Auerbach; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2003-12       Impact factor: 3.464

2.  Inferior vena cava filtration in the management of venous thromboembolism: filtering the data.

Authors:  Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

Review 3.  Optional inferior vena caval filters: where are we now?

Authors:  A N Keeling; T B Kinney; M J Lee
Journal:  Eur Radiol       Date:  2008-04-02       Impact factor: 5.315

4.  Temporary Vena Caval Interruption and Thrombolysis in the Management of Deep Vein Thrombosis.

Authors:  Gregg Elliott; Scott Stevens
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-06

5.  A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants.

Authors:  Amanda J Ghanim; Constantine Daskalakis; David J Eschelman; Walter K Kraft
Journal:  J Thromb Thrombolysis       Date:  2007-03-24       Impact factor: 2.300

6.  Inferior vena cava filters.

Authors:  Thomas B Kinney
Journal:  Semin Intervent Radiol       Date:  2006-09       Impact factor: 1.513

7.  Do inferior vena cava filters reduce the risk of acute pulmonary embolism in preoperative patients with venous thromboembolism?

Authors:  Juno Deguchi; Mikiko Nagayoshi; Takuya Miyahara; Seiji Nishikage; Hideo Kimura; Kunihiro Shigematsu; Tetsuro Miyata
Journal:  Surg Today       Date:  2010-05-23       Impact factor: 2.549

8.  Caval filters in intensive care: a retrospective study.

Authors:  F Ferraro; T L Di Gennaro; A Torino; J Petruzzi; A d'Elia; P Fusco; R Marfella; B Lettieri
Journal:  Drug Des Devel Ther       Date:  2014-11-06       Impact factor: 4.162

9.  Effectiveness of Inferior Vena Cava Filters without Anticoagulation Therapy for Prophylaxis of Recurrent Pulmonary Embolism.

Authors:  Miri Zektser; Carmi Bartal; Lior Zeller; Roman Nevzorov; Alan Jotkowitz; Vered Stavi; Vitaly Romanyuk; Gregory Chudakov; Leonid Barski
Journal:  Rambam Maimonides Med J       Date:  2016-07-28

10.  An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding.

Authors:  T Carter Chiasson; Braden J Manns; Henry Thomas Stelfox
Journal:  PLoS Med       Date:  2009-06-23       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.